DEVELOPMENT OF IMMUNE MONITORING REAGENTS AND MHC TYPING TECHNOLOGIES

免疫监测试剂和MHC分型技术的开发

基本信息

  • 批准号:
    8358206
  • 负责人:
  • 金额:
    $ 63.15万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2011
  • 资助国家:
    美国
  • 起止时间:
    2011-05-01 至 2012-04-30
  • 项目状态:
    已结题

项目摘要

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. Primary support for the subproject and the subproject's principal investigator may have been provided by other sources, including other NIH sources. The Total Cost listed for the subproject likely represents the estimated amount of Center infrastructure utilized by the subproject, not direct funding provided by the NCRR grant to the subproject or subproject staff. Objective: To develop and implement MHC typing technologies for Cynomolgus macaques (Macaca fascicularis) and Indian Rhesus macaques (Macaca mulatta). We will adapt technologies from HLA typing in humans for MHC class I and class II typing in the macaque. PROGRESS: cDNA libraries were constructed from seven Indian Rhesus macaques. These animals were completely characterized for their MHC class I and class II genes. Eleven novel MHC alleles were identified from these animals. At least two copies of each novel allele were full length sequenced in both directions, properly named and submitted to Genbank and the Immuno Polymorphism Database. Additionally, 11 new stably expressing transfectant cell lines were produced from cloned MHC alleles. PUBLICATIONS: Solomon C, Southwood S, Hoof I, Rudersdorf R, Peters B, Sidney J, Pinilla C, Marcondes MC, Ling B, Marx P, Sette A, Mothe BR. The most common Chinese rhesus macaque MHC class I molecule shares peptide binding repertoire with the HLA-B7 supertype. Immunogenetics. 2010 Jul;62(7):451-64. PMID: 20480161, PMCID: PMC2890073. Southwood S, Solomon C, Hoof I, Rudersdorf R, Sidney J, Peters B, Wahl A, Hawkins O, Hildebrand W, Moth¿ BR, Sette A. Functional analysis of frequently expressed Chinese rhesus macaque MHC class I. Immunogenetics. 2011 Jan 28. [Epub ahead of print]. PMID: 21274527. Note: AIDS related.
这个子项目是利用这些资源的众多研究子项目之一

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

David I Watkins其他文献

HIV pathogenesis: the first cut is the deepest
艾滋病病毒发病机制:初次感染影响最为深远
  • DOI:
    10.1038/ni0505-430
  • 发表时间:
    2005-05-01
  • 期刊:
  • 影响因子:
    27.600
  • 作者:
    Louis J Picker;David I Watkins
  • 通讯作者:
    David I Watkins

David I Watkins的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('David I Watkins', 18)}}的其他基金

Learning from the Ebola success: Can a mAb also save lives after yellow fever infection?
借鉴埃博拉病毒的成功经验:单克隆抗体也能拯救黄热病感染后的生命吗?
  • 批准号:
    10422995
  • 财政年份:
    2021
  • 资助金额:
    $ 63.15万
  • 项目类别:
Learning from the Ebola success: Can a mAb also save lives after yellow fever infection?
借鉴埃博拉病毒的成功经验:单克隆抗体也能拯救黄热病感染后的生命吗?
  • 批准号:
    10669613
  • 财政年份:
    2021
  • 资助金额:
    $ 63.15万
  • 项目类别:
Learning from the Ebola success: Can a mAb also save lives after yellow fever infection?
借鉴埃博拉病毒的成功经验:单克隆抗体也能拯救黄热病感染后的生命吗?
  • 批准号:
    10463875
  • 财政年份:
    2021
  • 资助金额:
    $ 63.15万
  • 项目类别:
Can vaccine-induced CD8 T cells prevent chronic phase AIDS virus replication?
疫苗诱导的 CD8 T 细胞能否阻止慢性期艾滋病病毒复制?
  • 批准号:
    8787712
  • 财政年份:
    2014
  • 资助金额:
    $ 63.15万
  • 项目类别:
Can vaccine-induced CD8 T cells prevent chronic phase AIDS virus replication?
疫苗诱导的 CD8 T 细胞能否阻止慢性期艾滋病病毒复制?
  • 批准号:
    8976140
  • 财政年份:
    2014
  • 资助金额:
    $ 63.15万
  • 项目类别:
Yellow Fever, rDNA (EP+IL-12) and rAd35 as Vectors for AIDS Vaccine Development
黄热病、rDNA (EP IL-12) 和 rAd35 作为艾滋病疫苗开发的载体
  • 批准号:
    8497605
  • 财政年份:
    2012
  • 资助金额:
    $ 63.15万
  • 项目类别:
Protective Immunity
保护性免疫
  • 批准号:
    8307106
  • 财政年份:
    2012
  • 资助金额:
    $ 63.15万
  • 项目类别:
Yellow Fever, rDNA (EP+IL-12) and rAd35 as Vectors for AIDS Vaccine Development
黄热病、rDNA (EP IL-12) 和 rAd35 作为艾滋病疫苗开发的载体
  • 批准号:
    8688135
  • 财政年份:
    2012
  • 资助金额:
    $ 63.15万
  • 项目类别:
Yellow Fever, rDNA (EP+IL-12) and rAd35 as Vectors for AIDS Vaccine Development
黄热病、rDNA (EP IL-12) 和 rAd35 作为艾滋病疫苗开发的载体
  • 批准号:
    8301117
  • 财政年份:
    2012
  • 资助金额:
    $ 63.15万
  • 项目类别:
Yellow Fever, rDNA (EP+IL-12) and rAd35 as Vectors for AIDS Vaccine Development
黄热病、rDNA (EP IL-12) 和 rAd35 作为艾滋病疫苗开发的载体
  • 批准号:
    8874851
  • 财政年份:
    2012
  • 资助金额:
    $ 63.15万
  • 项目类别:

相似海外基金

Linkage of HIV amino acid variants to protective host alleles at CHD1L and HLA class I loci in an African population
非洲人群中 HIV 氨基酸变异与 CHD1L 和 HLA I 类基因座的保护性宿主等位基因的关联
  • 批准号:
    502556
  • 财政年份:
    2024
  • 资助金额:
    $ 63.15万
  • 项目类别:
Olfactory Epithelium Responses to Human APOE Alleles
嗅觉上皮对人类 APOE 等位基因的反应
  • 批准号:
    10659303
  • 财政年份:
    2023
  • 资助金额:
    $ 63.15万
  • 项目类别:
Deeply analyzing MHC class I-restricted peptide presentation mechanistics across alleles, pathways, and disease coupled with TCR discovery/characterization
深入分析跨等位基因、通路和疾病的 MHC I 类限制性肽呈递机制以及 TCR 发现/表征
  • 批准号:
    10674405
  • 财政年份:
    2023
  • 资助金额:
    $ 63.15万
  • 项目类别:
An off-the-shelf tumor cell vaccine with HLA-matching alleles for the personalized treatment of advanced solid tumors
具有 HLA 匹配等位基因的现成肿瘤细胞疫苗,用于晚期实体瘤的个性化治疗
  • 批准号:
    10758772
  • 财政年份:
    2023
  • 资助金额:
    $ 63.15万
  • 项目类别:
Identifying genetic variants that modify the effect size of ApoE alleles on late-onset Alzheimer's disease risk
识别改变 ApoE 等位基因对迟发性阿尔茨海默病风险影响大小的遗传变异
  • 批准号:
    10676499
  • 财政年份:
    2023
  • 资助金额:
    $ 63.15万
  • 项目类别:
New statistical approaches to mapping the functional impact of HLA alleles in multimodal complex disease datasets
绘制多模式复杂疾病数据集中 HLA 等位基因功能影响的新统计方法
  • 批准号:
    2748611
  • 财政年份:
    2022
  • 资助金额:
    $ 63.15万
  • 项目类别:
    Studentship
Recessive lethal alleles linked to seed abortion and their effect on fruit development in blueberries
与种子败育相关的隐性致死等位基因及其对蓝莓果实发育的影响
  • 批准号:
    22K05630
  • 财政年份:
    2022
  • 资助金额:
    $ 63.15万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Genome and epigenome editing of induced pluripotent stem cells for investigating osteoarthritis risk alleles
诱导多能干细胞的基因组和表观基因组编辑用于研究骨关节炎风险等位基因
  • 批准号:
    10532032
  • 财政年份:
    2022
  • 资助金额:
    $ 63.15万
  • 项目类别:
Investigating the Effect of APOE Alleles on Neuro-Immunity of Human Brain Borders in Normal Aging and Alzheimer's Disease Using Single-Cell Multi-Omics and In Vitro Organoids
使用单细胞多组学和体外类器官研究 APOE 等位基因对正常衰老和阿尔茨海默病中人脑边界神经免疫的影响
  • 批准号:
    10525070
  • 财政年份:
    2022
  • 资助金额:
    $ 63.15万
  • 项目类别:
Leveraging the Evolutionary History to Improve Identification of Trait-Associated Alleles and Risk Stratification Models in Native Hawaiians
利用进化历史来改进夏威夷原住民性状相关等位基因的识别和风险分层模型
  • 批准号:
    10689017
  • 财政年份:
    2022
  • 资助金额:
    $ 63.15万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了